SlideShare una empresa de Scribd logo
1 de 4
Descargar para leer sin conexión
Hexa Reports
Market Research Reports and Insightful Company Profiles
Global Vancomycin-Resistant Enterococcus Faecium Infections
Industry 2015 Market Share, Size, Industry Profile, Market Prize,
Forecast and Overview
Global Markets Direct's, 'Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1
2015', provides an overview of the Vancomycin-Resistant Enterococcus Faecium Infections's therapeutic
pipeline.
This report provides comprehensive information on the therapeutic development for Vancomycin-
Resistant Enterococcus Faecium Infections, complete with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and press releases. It also reviews key
players involved in the therapeutic development for Vancomycin-Resistant Enterococcus Faecium
Infections and special features on late-stage and discontinued projects.
Browse Detail Report With TOC @ http://www.hexareports.com/report/vancomycin-resistant-
enterococcus-faecium-infections-pipeline-review-h1-2015/details
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third
party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the
report undergoes periodic updation following a stringent set of processes that ensures that all the
Hexa Reports
Market Research Reports and Insightful Company Profiles
profiles are updated with the latest set of information. Additionally, processes including live news &
deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance
of data for the indicated disease.
Scope
 The report provides a snapshot of the global therapeutic landscape of Vancomycin-Resistant
Enterococcus Faecium Infections
 The report reviews key pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details & other developmental
activities
 The report reviews key players involved in the therapeutics development for Vancomycin-
Resistant Enterococcus Faecium Infections and enlists all their major and minor projects
 The report summarizes all the dormant and discontinued pipeline projects
 A review of the Vancomycin-Resistant Enterococcus Faecium Infections products under
development by companies and universities/research institutes based on information derived
from company and industry-specific sources
 Pipeline products coverage based on various stages of development ranging from pre-
registration till discovery and undisclosed stages
 A detailed assessment of monotherapy and combination therapy pipeline projects
 Coverage of the Vancomycin-Resistant Enterococcus Faecium Infections pipeline on the basis of
target, MoA, route of administration and molecule type
 Latest news and deals relating related to pipeline products
Reasons to buy
 Provides strategically significant competitor information, analysis, and insights to formulate
effective R&D development strategies
 Identify emerging players with potentially strong product portfolio and create effective counter-
strategies to gain competitive advantage
 Develop strategic initiatives by understanding the focus areas of leading companies
 Identify and understand important and diverse types of therapeutics under development for
Vancomycin-Resistant Enterococcus Faecium Infections
Hexa Reports
Market Research Reports and Insightful Company Profiles
 Plan mergers and acquisitions effectively by identifying key players of the most promising
pipeline
 Devise corrective measures for pipeline projects by understanding Vancomycin-Resistant
Enterococcus Faecium Infections pipeline depth and focus of Indication therapeutics
 Develop and design in-licensing and out-licensing strategies by identifying prospective partners
with the most attractive projects to enhance and expand business potential and Scope
 Modify the therapeutic portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline
Request A Sample copy of This Report @ http://www.hexareports.com/sample/47458
Table Of Content
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Vancomycin-Resistant Enterococcus Faecium Infections Overview 9
Therapeutics Development 10
Pipeline Products for Vancomycin-Resistant Enterococcus Faecium Infections - Overview 10
Pipeline Products for Vancomycin-Resistant Enterococcus Faecium Infections - Comparative Analysis 11
Vancomycin-Resistant Enterococcus Faecium Infections - Therapeutics under Development by
Companies 12
Vancomycin-Resistant Enterococcus Faecium Infections - Therapeutics under Investigation by
Universities/Institutes 14
Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Products Glance 15
Clinical Stage Products 15
Early Stage Products 16
Vancomycin-Resistant Enterococcus Faecium Infections - Products under Development by Companies 17
Vancomycin-Resistant Enterococcus Faecium Infections - Products under Investigation by
Universities/Institutes 19
Vancomycin-Resistant Enterococcus Faecium Infections - Companies Involved in Therapeutics
Development 20
Alchemia Limited 20
Alvogen, Inc. 21
Aphios Corporation 22
Cellceutix Corporation 23
Enanta Pharmaceuticals, Inc. 24
Helix BioMedix, Inc. 25
LegoChem Biosciences, Inc 26
Lytix Biopharma AS 27
Hexa Reports
Market Research Reports and Insightful Company Profiles
MGB Biopharma Limited 28
Microbiotix, Inc. 29
MicuRx Pharmaceuticals, Inc. 30
Nabriva Therapeutics AG 31
NovaBay Pharmaceuticals, Inc. 32
NovoBiotic Pharmaceuticals, LLC 33
Oragenics, Inc. 34
Sealife PHARMA GMBH 35
Sentinella Pharmaceuticals, Inc. 36
TAXIS Pharmaceuticals, Inc. 37
Wockhardt Limited 38
Vancomycin-Resistant Enterococcus Faecium Infections - Therapeutics Assessment 39
Assessment by Monotherapy Products 39
Assessment by Target 40
Assessment by Mechanism of Action 42
Assessment by Route of Administration 44
Assessment by Molecule Type 46
Drug Profiles 48
Browse Full Report @ http://www.hexareports.com/report/vancomycin-resistant-enterococcus-
faecium-infections-pipeline-review-h1-2015/details
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: sales@hexareports.com
Our Website: http://www.hexareports.com/
Our Blogs: http://hexareports.blogspot.in

Más contenido relacionado

Destacado

Catalogo Set Decoden
Catalogo Set DecodenCatalogo Set Decoden
Catalogo Set Decodenguest3c0dc09
 
Af1 donde habitaentusiasmo_pres
Af1 donde habitaentusiasmo_presAf1 donde habitaentusiasmo_pres
Af1 donde habitaentusiasmo_presgruporecrea
 
Chapter 4.1 product management
Chapter 4.1 product managementChapter 4.1 product management
Chapter 4.1 product managementpetra vijncke
 
UNIVERSUM Group - Zusammenfassung
UNIVERSUM Group - ZusammenfassungUNIVERSUM Group - Zusammenfassung
UNIVERSUM Group - ZusammenfassungUNIVERSUM Group
 
Ser Community Manager y No Morir en el Intento (PRIMERA PARTE)
Ser Community Manager y No Morir en el Intento (PRIMERA PARTE)Ser Community Manager y No Morir en el Intento (PRIMERA PARTE)
Ser Community Manager y No Morir en el Intento (PRIMERA PARTE)Carlos Vargas H.
 
10 useful sar (sysstat) examples for unix : linux performance monitoring
10 useful sar (sysstat) examples for unix : linux performance monitoring10 useful sar (sysstat) examples for unix : linux performance monitoring
10 useful sar (sysstat) examples for unix : linux performance monitoringchinkshady
 
Overhead Cranes, Jib Cranes, Commercial Doors & Loading Dock Equipment - O'Br...
Overhead Cranes, Jib Cranes, Commercial Doors & Loading Dock Equipment - O'Br...Overhead Cranes, Jib Cranes, Commercial Doors & Loading Dock Equipment - O'Br...
Overhead Cranes, Jib Cranes, Commercial Doors & Loading Dock Equipment - O'Br...O'Brien Installations Limited
 
Der spiegel januar 2016
Der spiegel    januar 2016Der spiegel    januar 2016
Der spiegel januar 2016xachtay giare
 
I I K D For Public Info Version II
I I K D  For  Public  Info Version III I K D  For  Public  Info Version II
I I K D For Public Info Version IImonacofamily
 
Programa I I I Curso Intensivo De Sutura LaparoscóPica
Programa  I I I  Curso  Intensivo De  Sutura  LaparoscóPicaPrograma  I I I  Curso  Intensivo De  Sutura  LaparoscóPica
Programa I I I Curso Intensivo De Sutura LaparoscóPicaIgnacio Cristóbal Garcia
 
Tourism Distribution in a Changed World
Tourism Distribution in a Changed WorldTourism Distribution in a Changed World
Tourism Distribution in a Changed WorldCaucaseastan
 
VICTIMS OF MUNITIONS in Lezhe and Shkoder Counties
VICTIMS OF MUNITIONS in Lezhe and Shkoder CountiesVICTIMS OF MUNITIONS in Lezhe and Shkoder Counties
VICTIMS OF MUNITIONS in Lezhe and Shkoder CountiesALB-AID Kukes
 

Destacado (16)

Equipo Negro
Equipo NegroEquipo Negro
Equipo Negro
 
Marre Infinito- Revista MIID 4° edição
Marre Infinito- Revista MIID 4° ediçãoMarre Infinito- Revista MIID 4° edição
Marre Infinito- Revista MIID 4° edição
 
Catalogo Set Decoden
Catalogo Set DecodenCatalogo Set Decoden
Catalogo Set Decoden
 
Arbeiten in Deutschland - Linsammlung (Working in Germany - Link List )
Arbeiten in Deutschland - Linsammlung (Working in Germany - Link List )Arbeiten in Deutschland - Linsammlung (Working in Germany - Link List )
Arbeiten in Deutschland - Linsammlung (Working in Germany - Link List )
 
Af1 donde habitaentusiasmo_pres
Af1 donde habitaentusiasmo_presAf1 donde habitaentusiasmo_pres
Af1 donde habitaentusiasmo_pres
 
Chapter 4.1 product management
Chapter 4.1 product managementChapter 4.1 product management
Chapter 4.1 product management
 
UNIVERSUM Group - Zusammenfassung
UNIVERSUM Group - ZusammenfassungUNIVERSUM Group - Zusammenfassung
UNIVERSUM Group - Zusammenfassung
 
Ser Community Manager y No Morir en el Intento (PRIMERA PARTE)
Ser Community Manager y No Morir en el Intento (PRIMERA PARTE)Ser Community Manager y No Morir en el Intento (PRIMERA PARTE)
Ser Community Manager y No Morir en el Intento (PRIMERA PARTE)
 
10 useful sar (sysstat) examples for unix : linux performance monitoring
10 useful sar (sysstat) examples for unix : linux performance monitoring10 useful sar (sysstat) examples for unix : linux performance monitoring
10 useful sar (sysstat) examples for unix : linux performance monitoring
 
Overhead Cranes, Jib Cranes, Commercial Doors & Loading Dock Equipment - O'Br...
Overhead Cranes, Jib Cranes, Commercial Doors & Loading Dock Equipment - O'Br...Overhead Cranes, Jib Cranes, Commercial Doors & Loading Dock Equipment - O'Br...
Overhead Cranes, Jib Cranes, Commercial Doors & Loading Dock Equipment - O'Br...
 
Marketing digital
Marketing digitalMarketing digital
Marketing digital
 
Der spiegel januar 2016
Der spiegel    januar 2016Der spiegel    januar 2016
Der spiegel januar 2016
 
I I K D For Public Info Version II
I I K D  For  Public  Info Version III I K D  For  Public  Info Version II
I I K D For Public Info Version II
 
Programa I I I Curso Intensivo De Sutura LaparoscóPica
Programa  I I I  Curso  Intensivo De  Sutura  LaparoscóPicaPrograma  I I I  Curso  Intensivo De  Sutura  LaparoscóPica
Programa I I I Curso Intensivo De Sutura LaparoscóPica
 
Tourism Distribution in a Changed World
Tourism Distribution in a Changed WorldTourism Distribution in a Changed World
Tourism Distribution in a Changed World
 
VICTIMS OF MUNITIONS in Lezhe and Shkoder Counties
VICTIMS OF MUNITIONS in Lezhe and Shkoder CountiesVICTIMS OF MUNITIONS in Lezhe and Shkoder Counties
VICTIMS OF MUNITIONS in Lezhe and Shkoder Counties
 

Último

UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8DianaGray10
 
Designing A Time bound resource download URL
Designing A Time bound resource download URLDesigning A Time bound resource download URL
Designing A Time bound resource download URLRuncy Oommen
 
AI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity WebinarAI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity WebinarPrecisely
 
OpenShift Commons Paris - Choose Your Own Observability Adventure
OpenShift Commons Paris - Choose Your Own Observability AdventureOpenShift Commons Paris - Choose Your Own Observability Adventure
OpenShift Commons Paris - Choose Your Own Observability AdventureEric D. Schabell
 
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDEADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDELiveplex
 
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...Aggregage
 
Cybersecurity Workshop #1.pptx
Cybersecurity Workshop #1.pptxCybersecurity Workshop #1.pptx
Cybersecurity Workshop #1.pptxGDSC PJATK
 
VoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBXVoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBXTarek Kalaji
 
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdf
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdf
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdfJamie (Taka) Wang
 
UiPath Studio Web workshop series - Day 6
UiPath Studio Web workshop series - Day 6UiPath Studio Web workshop series - Day 6
UiPath Studio Web workshop series - Day 6DianaGray10
 
Basic Building Blocks of Internet of Things.
Basic Building Blocks of Internet of Things.Basic Building Blocks of Internet of Things.
Basic Building Blocks of Internet of Things.YounusS2
 
COMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a WebsiteCOMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a Websitedgelyza
 
Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024D Cloud Solutions
 
UiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPathCommunity
 
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Will Schroeder
 
Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1DianaGray10
 
NIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 WorkshopNIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 WorkshopBachir Benyammi
 
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...DianaGray10
 
UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7DianaGray10
 

Último (20)

UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8
 
Designing A Time bound resource download URL
Designing A Time bound resource download URLDesigning A Time bound resource download URL
Designing A Time bound resource download URL
 
AI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity WebinarAI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity Webinar
 
OpenShift Commons Paris - Choose Your Own Observability Adventure
OpenShift Commons Paris - Choose Your Own Observability AdventureOpenShift Commons Paris - Choose Your Own Observability Adventure
OpenShift Commons Paris - Choose Your Own Observability Adventure
 
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDEADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
 
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
 
Cybersecurity Workshop #1.pptx
Cybersecurity Workshop #1.pptxCybersecurity Workshop #1.pptx
Cybersecurity Workshop #1.pptx
 
20150722 - AGV
20150722 - AGV20150722 - AGV
20150722 - AGV
 
VoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBXVoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBX
 
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdf
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdf
activity_diagram_combine_v4_20190827.pdfactivity_diagram_combine_v4_20190827.pdf
 
UiPath Studio Web workshop series - Day 6
UiPath Studio Web workshop series - Day 6UiPath Studio Web workshop series - Day 6
UiPath Studio Web workshop series - Day 6
 
Basic Building Blocks of Internet of Things.
Basic Building Blocks of Internet of Things.Basic Building Blocks of Internet of Things.
Basic Building Blocks of Internet of Things.
 
COMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a WebsiteCOMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a Website
 
Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024
 
UiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation Developers
 
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
 
Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1
 
NIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 WorkshopNIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 Workshop
 
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...
Connector Corner: Extending LLM automation use cases with UiPath GenAI connec...
 
UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7
 

Vancomycin-Resistant Enterococcus Faecium Infections Market Size, Share, Regional Outlook, Competitive Strategies And Forecasts,Pipeline Review 2015

  • 1. Hexa Reports Market Research Reports and Insightful Company Profiles Global Vancomycin-Resistant Enterococcus Faecium Infections Industry 2015 Market Share, Size, Industry Profile, Market Prize, Forecast and Overview Global Markets Direct's, 'Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Review, H1 2015', provides an overview of the Vancomycin-Resistant Enterococcus Faecium Infections's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vancomycin- Resistant Enterococcus Faecium Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections and special features on late-stage and discontinued projects. Browse Detail Report With TOC @ http://www.hexareports.com/report/vancomycin-resistant- enterococcus-faecium-infections-pipeline-review-h1-2015/details Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the
  • 2. Hexa Reports Market Research Reports and Insightful Company Profiles profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope  The report provides a snapshot of the global therapeutic landscape of Vancomycin-Resistant Enterococcus Faecium Infections  The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities  The report reviews key players involved in the therapeutics development for Vancomycin- Resistant Enterococcus Faecium Infections and enlists all their major and minor projects  The report summarizes all the dormant and discontinued pipeline projects  A review of the Vancomycin-Resistant Enterococcus Faecium Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources  Pipeline products coverage based on various stages of development ranging from pre- registration till discovery and undisclosed stages  A detailed assessment of monotherapy and combination therapy pipeline projects  Coverage of the Vancomycin-Resistant Enterococcus Faecium Infections pipeline on the basis of target, MoA, route of administration and molecule type  Latest news and deals relating related to pipeline products Reasons to buy  Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies  Identify emerging players with potentially strong product portfolio and create effective counter- strategies to gain competitive advantage  Develop strategic initiatives by understanding the focus areas of leading companies  Identify and understand important and diverse types of therapeutics under development for Vancomycin-Resistant Enterococcus Faecium Infections
  • 3. Hexa Reports Market Research Reports and Insightful Company Profiles  Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline  Devise corrective measures for pipeline projects by understanding Vancomycin-Resistant Enterococcus Faecium Infections pipeline depth and focus of Indication therapeutics  Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope  Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Request A Sample copy of This Report @ http://www.hexareports.com/sample/47458 Table Of Content Table of Contents 2 List of Tables 6 List of Figures 7 Introduction 8 Global Markets Direct Report Coverage 8 Vancomycin-Resistant Enterococcus Faecium Infections Overview 9 Therapeutics Development 10 Pipeline Products for Vancomycin-Resistant Enterococcus Faecium Infections - Overview 10 Pipeline Products for Vancomycin-Resistant Enterococcus Faecium Infections - Comparative Analysis 11 Vancomycin-Resistant Enterococcus Faecium Infections - Therapeutics under Development by Companies 12 Vancomycin-Resistant Enterococcus Faecium Infections - Therapeutics under Investigation by Universities/Institutes 14 Vancomycin-Resistant Enterococcus Faecium Infections - Pipeline Products Glance 15 Clinical Stage Products 15 Early Stage Products 16 Vancomycin-Resistant Enterococcus Faecium Infections - Products under Development by Companies 17 Vancomycin-Resistant Enterococcus Faecium Infections - Products under Investigation by Universities/Institutes 19 Vancomycin-Resistant Enterococcus Faecium Infections - Companies Involved in Therapeutics Development 20 Alchemia Limited 20 Alvogen, Inc. 21 Aphios Corporation 22 Cellceutix Corporation 23 Enanta Pharmaceuticals, Inc. 24 Helix BioMedix, Inc. 25 LegoChem Biosciences, Inc 26 Lytix Biopharma AS 27
  • 4. Hexa Reports Market Research Reports and Insightful Company Profiles MGB Biopharma Limited 28 Microbiotix, Inc. 29 MicuRx Pharmaceuticals, Inc. 30 Nabriva Therapeutics AG 31 NovaBay Pharmaceuticals, Inc. 32 NovoBiotic Pharmaceuticals, LLC 33 Oragenics, Inc. 34 Sealife PHARMA GMBH 35 Sentinella Pharmaceuticals, Inc. 36 TAXIS Pharmaceuticals, Inc. 37 Wockhardt Limited 38 Vancomycin-Resistant Enterococcus Faecium Infections - Therapeutics Assessment 39 Assessment by Monotherapy Products 39 Assessment by Target 40 Assessment by Mechanism of Action 42 Assessment by Route of Administration 44 Assessment by Molecule Type 46 Drug Profiles 48 Browse Full Report @ http://www.hexareports.com/report/vancomycin-resistant-enterococcus- faecium-infections-pipeline-review-h1-2015/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Our Blogs: http://hexareports.blogspot.in